======= ZBTB16 ======= == Gene Information == * **Official Symbol**: ZBTB16 * **Official Name**: zinc finger and BTB domain containing 16 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7704|7704]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q05516|Q05516]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZBTB16&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZBTB16|Open PubMed]] * **OMIM**: [[https://omim.org/entry/176797|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of the Krueppel C2H2-type zinc-finger protein family and encodes a zinc finger transcription factor that contains nine Kruppel-type zinc finger domains at the carboxyl terminus. This protein is located in the nucleus, is involved in cell cycle progression, and interacts with a histone deacetylase. Specific instances of aberrant gene rearrangement at this locus have been associated with acute promyelocytic leukemia (APL). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Probable transcription factor. May play a role in myeloid maturation and in the development and/or maintenance of other differentiated tissues. Probable substrate-recognition component of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000269|PubMed:14528312}. |BTB| |positive regulation of NK T cell differentiation| |male germ-line stem cell asymmetric division| |germ-line stem cell division| |germline stem cell asymmetric division| |regulation of NK T cell differentiation| |asymmetric stem cell division| |asymmetric cell division| |positive regulation of chondrocyte differentiation| |embryonic hindlimb morphogenesis| |positive regulation of cartilage development| |stem cell division| |hindlimb morphogenesis| |forelimb morphogenesis| |positive regulation of alpha-beta T cell differentiation| |regulation of chondrocyte differentiation| |transcriptional repressor complex| |positive regulation of alpha-beta T cell activation| |embryonic digit morphogenesis| |positive regulation of fat cell differentiation| |regulation of alpha-beta T cell differentiation| |embryonic pattern specification| |regulation of cartilage development| |negative regulation of myeloid cell differentiation| |positive regulation of T cell differentiation| |positive regulation of ossification| |mesonephros development| |regulation of alpha-beta T cell activation| |positive regulation of lymphocyte differentiation| |RNA polymerase II distal enhancer sequence-specific DNA binding| |PML body| |regulation of fat cell differentiation| |embryonic appendage morphogenesis| |embryonic limb morphogenesis| |negative regulation of hemopoiesis| |regulation of T cell differentiation| |positive regulation of leukocyte differentiation| |limb morphogenesis| |appendage morphogenesis| |protein localization to nucleus| |regulation of lymphocyte differentiation| |cartilage development| |limb development| |appendage development| |positive regulation of hemopoiesis| |protein C-terminus binding| |regulation of ossification| |positive regulation of T cell activation| |positive regulation of leukocyte cell-cell adhesion| |anterior/posterior pattern specification| |myeloid cell differentiation| |connective tissue development| |regulation of myeloid cell differentiation| |protein domain specific binding| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |positive regulation of cell-cell adhesion| |germ cell development| |kidney development| |regulation of leukocyte differentiation| |nuclear body| |renal system development| |regulation of leukocyte cell-cell adhesion| |regulation of T cell activation| |urogenital system development| |regionalization| |cellular process involved in reproduction in multicellular organism| |positive regulation of lymphocyte activation| |post-translational protein modification| |regulation of cell-cell adhesion| |nuclear speck| |positive regulation of cell adhesion| |positive regulation of leukocyte activation| |positive regulation of cell activation| |sequence-specific DNA binding| |pattern specification process| |negative regulation of immune system process| |regulation of hemopoiesis| |cell division| |skeletal system development| |regulation of lymphocyte activation| |spermatogenesis| |hemopoiesis| |male gamete generation| |embryonic morphogenesis| |protein-containing complex| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |regulation of cell activation| |positive regulation of apoptotic process| |immune system development| |positive regulation of programmed cell death| |developmental process involved in reproduction| |DNA-binding transcription factor activity| |negative regulation of cell population proliferation| |regulation of cell adhesion| |protein ubiquitination| |gamete generation| |positive regulation of cell death| |negative regulation of cell differentiation| |protein localization to organelle| |protein modification by small protein conjugation| |multicellular organismal reproductive process| |sexual reproduction| |multicellular organism reproduction| |negative regulation of transcription by RNA polymerase II| |protein homodimerization activity| |apoptotic process| |negative regulation of developmental process| |positive regulation of cell differentiation| |embryo development| |central nervous system development| |protein modification by small protein conjugation or removal| |multi-organism reproductive process| |programmed cell death| |identical protein binding| |cell death| |positive regulation of immune system process| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |cellular protein localization| |cellular macromolecule localization| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |regulation of immune system process| |regulation of cell death| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp534|Trientine 500μM R08 exp534]]|-2| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|2.05| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7257 * **Expression level (log2 read counts)**: 2.0 {{:chemogenomics:nalm6 dist.png?nolink |}}